** Shares of Procter & Gamble Health PROR.NS rise as much
as 15.6% to 4,743 rupees, mark sharpest intraday pct gain since
May 17, 2019
** Stock hits highest level since Feb. 17, 2022; on track
for a second consecutive session of gain
** Co on Sunday reported 71.3% Y/Y rise in Q3 net profit and
11.5% rev growth; declared interim dividend of 45 rupees per shr
** PROR's relative strength index (RSI) is above 70,
indicating that it is overbought
** Share price is above the 50-day, 100-day and 200-day
exponential moving average, suggesting bullish trend
** Stock is witnessing its most active trading session in
over 2 yrs since Sept. 18, 2020
** More than 103,000 shares change hands by 12:42 p.m. IST,
13.7x 30-day avg of 7,555 shares
** One analyst covering the stock has a "buy" rating; median
PT is 5,235 rupees - Refinitiv data
** Stock fell ~26% in 2022
(Reporting by Ashish Chandra in Bengaluru)
((ashish.chandra@thomsonreuters.com (+91 7982114624))